Well Pharmaceutical (603351.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

Well Pharmaceutical released FY2025 9 Months Earnings on October 29 Pre-Market BJT, actual revenue CNY 1.018 B, actual EPS CNY 0.8395

01:00

Well Pharmaceutical released FY2025 Q3 earnings on October 29 Pre-Market (BJT), actual revenue CNY 344.52 M, actual EPS CNY 0.2995

01:00

Oct22

Well Pharmaceutical to Release FY2025 Q3 Earnings on October 30 Pre-Market BJT

01:22

Aug19

Well Pharmaceutical released FY2025 semi-annual earnings on August 19 After-Market (BJT), actual revenue CNY 673.72 M, actual EPS CNY 0.54

01:00

Well Pharmaceutical released FY2025 Q2 earnings on August 19 After-Market (BJT), actual revenue CNY 324 M, actual EPS CNY 0.27

01:00

Aug12

Well Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)

00:09

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 344.52 M, Net Income 41.3 M, EPS 0.2995

Aug20

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 324 M, Net Income 36.18 M, EPS 0.27

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More